Prediction of 'highly skin smear positive' cases among MB leprosy patients using clinical parameters

Leprosy Review

Volumn 72, Issue 1, 2001, Pages 23-28

  LeMaster, J W ^a   Shwe, T ^a   Butlin, C R ^a   Roche, P W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; LEPROSTATIC AGENT; PHENOLIC GLYCOLIPID I;

ADULT; ARTICLE; BORDERLINE LEPROSY; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MALE; NEPAL; RELAPSE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMEAR;

EID: 0035059343     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.20010005     Document Type: Article

References (9)

1. Fixed duration multidrug therapy in leprosy - A preliminary follow-up report
2. Why multidrug therapy for multibacillary leprosy can be shortened to 12 months
3. Relapse after long-term follow-up of multibacillary patients treated by WHO multidrug regimen
4. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens
5. Relapse following various types of multidrug therapy in multibacillary leprosy
6. Risk factors for erythema nodosum leprosum